Literature DB >> 8292452

Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors.

S Kosuda1, H Fujii, S Aoki, K Suzuki, Y Tanaka, O Nakamura, N Shidara.   

Abstract

In order to reassess the value of quantitative thallium-201 brain SPECT in the differentiation of miscellaneous brain tumors, we studied a total of 89 patients--35 pre-operative patients suspected of having a brain tumor and 54 post-operative patients with a brain tumor. We came to the conclusion that quantitative Tl-201 brain SPECT was very useful in discriminating cerebral radiation necrosis from recurrent tumor, estimating residual tumor burden, and detecting tumor regrowth earlier in postoperative patients. In preoperative patients, however, Tl-201 SPECT cannot be used effectively to differentiate glioma from other intracranial tumors, although intense uptake of Tl-201 may provide evidence of glioblastoma or a hypervascular lesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292452     DOI: 10.1007/BF03164707

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  16 in total

1.  Delayed radiation necrosis of the brain.

Authors:  A N Martins; J S Johnston; J M Henry; T J Stoffel; G Di Chiro
Journal:  J Neurosurg       Date:  1977-09       Impact factor: 5.115

2.  Radiation necrosis of the brain. Neuroradiological considerations with computed tomography.

Authors:  J Brismar; G H Roberson; K R Davis
Journal:  Neuroradiology       Date:  1976-11-11       Impact factor: 2.804

3.  Thallium-201 SPECT imaging of brain tumors: methods and results.

Authors:  K T Kim; K L Black; D Marciano; J C Mazziotta; B H Guze; S Grafton; R A Hawkins; D P Becker
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

4.  Enhanced Na+-K+-activated adenosine triphosphatase activity in transformed fibroblasts.

Authors:  L B Kasărov; H Friedman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

5.  Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation.

Authors:  D A Graeb; P Steinbok; W D Robertson
Journal:  Radiology       Date:  1982-09       Impact factor: 11.105

6.  Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.

Authors:  K Mineura; T Sasajima; M Kowada; Y Uesaka; F Shishido
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

7.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

8.  Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO.

Authors:  R B Schwartz; P A Carvalho; E Alexander; J S Loeffler; R Folkerth; B L Holman
Journal:  AJNR Am J Neuroradiol       Date:  1991 Nov-Dec       Impact factor: 3.825

9.  Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.

Authors:  W D Kaplan; T Takvorian; J H Morris; C L Rumbaugh; B T Connolly; H L Atkins
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

10.  Radiation effects on cerebral white matter: MR evaluation.

Authors:  J S Tsuruda; K E Kortman; W G Bradley; D C Wheeler; W Van Dalsem; T P Bradley
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

View more
  9 in total

1.  Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.

Authors:  M F Roesdi; T J Postma; O S Hoekstra; C J van Groeningen; J G Wolbers; J J Heimans
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

2.  MRI and thallium-201 SPECT in the prediction of survival in glioma.

Authors:  Maaike J Vos; Johannes Berkhof; Otto S Hoekstra; Ingeborg Bosma; Eefje M Sizoo; Jan J Heimans; Jaap C Reijneveld; Esther Sanchez; Frank J Lagerwaard; Jan Buter; David P Noske; Tjeerd J Postma
Journal:  Neuroradiology       Date:  2011-07-14       Impact factor: 2.804

3.  Usefulness of Ga-67 brain SPECT in patients with CNS malignant lymphoma.

Authors:  H Fujii; S Kosuda; K Suzuki; H Yorino; S Akita; H Negishi; O Nakamura; N Shitara; A Kubo
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

4.  Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas.

Authors:  Tetsuji Takeda; Takahiro Nakano; Kenichiroh Asano; Norihito Shimamura; Hiroki Ohkuma
Journal:  Neuroradiology       Date:  2011-01-08       Impact factor: 2.804

5.  Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.

Authors:  Amr Amin; Hosna Moustafa; Ebaa Ahmed; Mohamed El-Toukhy
Journal:  J Neurooncol       Date:  2011-09-13       Impact factor: 4.130

6.  The effect of steroid on thallium-201 uptake by malignant gliomas.

Authors:  H Namba; T Togawa; N Yui; M Yanagisawa; F Kinoshita; Y Iwadate; K Ohsato; K Sueyoshi
Journal:  Eur J Nucl Med       Date:  1996-08

Review 7.  Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Spyridon Voulgaris; Maria I Argyropoulou; Andreas D Fotopoulos
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

Review 8.  Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

Authors:  Ashish H Shah; Brian Snelling; Amade Bregy; Payal R Patel; Danoushka Tememe; Rita Bhatia; Evelyn Sklar; Ricardo J Komotar
Journal:  J Neurooncol       Date:  2013-01-24       Impact factor: 4.130

9.  Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.

Authors:  Moritaka Yamauchi; Tomohisa Okada; Tsutomu Okada; Akira Yamamoto; Yasutaka Fushimi; Yoshiki Arakawa; Susumu Miyamoto; Kaori Togashi
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.